Literature DB >> 17696457

Amorphous drug nanosuspensions. 3. Particle dissolution and crystal growth.

Lennart Lindfors1, Pia Skantze, Urban Skantze, Jan Westergren, Ulf Olsson.   

Abstract

In the present paper, we have studied particle dissolution and crystal growth of the poorly water soluble drug felodipine, using fluorescence as a probe for the amount of crystalline material. Dissolution kinetics is essentially diffusion-controlled, while the rate of crystal growth is significantly slower compared to the diffusion-controlled limit. The deviation from diffusion control was characterized by the effective length, lambda, related to the kinetics of a surface integration process. Amorphous nanoparticles may be highly unstable in the presence of small amounts of crystalline particles. This is due to the fact that the molecular solubility from the amorphous nanoparticles often is at least an order of magnitude higher than the corresponding crystalline solubility. In a mixed system where crystalline nanoparticles have been added to an amorphous nanosuspension, the bulk will have a monomer concentration intermediate between the amorphous and crystalline solubilities, and is thus supersaturated with respect to the crystalline particles while being undersaturated with respect to the amorphous particles. As a consequence, the amorphous particles spontaneously dissolve, while crystalline particles grow, in a combined process which is similar to Ostwald ripening. By knowing the parameters describing dissolution and crystal growth, respectively, it was possible to simulate the outcome of controlled seeding experiments, where a small amount of crystalline nanoparticles was added to a dispersion of amorphous nanoparticles. A good agreement between model calculations and experiments was obtained including how the crystal growth rate varied with the amounts of added crystalline seeds.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17696457     DOI: 10.1021/la700811b

Source DB:  PubMed          Journal:  Langmuir        ISSN: 0743-7463            Impact factor:   3.882


  18 in total

1.  Influence of particle size on the ultraviolet spectrum of particulate-containing solutions: implications for in-situ concentration monitoring using UV/Vis fiber-optic probes.

Authors:  Bernard Van Eerdenbrugh; David E Alonzo; Lynne S Taylor
Journal:  Pharm Res       Date:  2011-03-04       Impact factor: 4.200

2.  Polymer-mediated anti-solvent crystallization of nitrendipine: monodispersed spherical crystals and growth mechanism.

Authors:  Dengning Xia; Mei Ouyang; Jian X Wu; Yanbo Jiang; Hongyu Piao; Shaoping Sun; Li Zheng; Jukka Rantanen; Fude Cui; Mingshi Yang
Journal:  Pharm Res       Date:  2011-07-12       Impact factor: 4.200

3.  Size Control in the Nanoprecipitation Process of Stable Iodine (¹²⁷I) Using Microchannel Reactor-Optimization by Artificial Neural Networks.

Authors:  Mohamad Hosein Aghajani; Ali Mahmoud Pashazadeh; Seyed Hossein Mostafavi; Shayan Abbasi; Mohammad-Javad Hajibagheri-Fard; Majid Assadi; Mahdi Aghajani
Journal:  AAPS PharmSciTech       Date:  2015-02-06       Impact factor: 3.246

4.  Influence of formulation and processing variables on properties of itraconazole nanoparticles made by advanced evaporative precipitation into aqueous solution.

Authors:  Stephanie Bosselmann; Masao Nagao; Keat T Chow; Robert O Williams
Journal:  AAPS PharmSciTech       Date:  2012-06-30       Impact factor: 3.246

5.  Predicting intestinal precipitation--a case example for a basic BCS class II drug.

Authors:  Sara Carlert; Anna Pålsson; Gunilla Hanisch; Christian von Corswant; Catarina Nilsson; Lennart Lindfors; Hans Lennernäs; Bertil Abrahamsson
Journal:  Pharm Res       Date:  2010-08-18       Impact factor: 4.200

6.  Pure insulin nanoparticle agglomerates for pulmonary delivery.

Authors:  Mark M Bailey; Eric M Gorman; Eric J Munson; Cory Berkland
Journal:  Langmuir       Date:  2008-12-02       Impact factor: 3.882

7.  Budesonide nanoparticle agglomerates as dry powder aerosols with rapid dissolution.

Authors:  Nashwa El-Gendy; Eric M Gorman; Eric J Munson; Cory Berkland
Journal:  J Pharm Sci       Date:  2009-08       Impact factor: 3.534

8.  Colloidal aggregation: from screening nuisance to formulation nuance.

Authors:  Ahil N Ganesh; Eric N Donders; Brian K Shoichet; Molly S Shoichet
Journal:  Nano Today       Date:  2018-03-10       Impact factor: 20.722

9.  Nanocrystals for the parenteral delivery of poorly water-soluble drugs.

Authors:  Bo Sun; Yoon Yeo
Journal:  Curr Opin Solid State Mater Sci       Date:  2012-12-01       Impact factor: 11.354

10.  Combination chemotherapeutic dry powder aerosols via controlled nanoparticle agglomeration.

Authors:  Nashwa El-Gendy; Cory Berkland
Journal:  Pharm Res       Date:  2009-05-05       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.